Core Viewpoint - AdaptHealth Corp. reported quarterly earnings of $0.01 per share, missing the Zacks Consensus Estimate of $0.15 per share, representing a significant earnings surprise of -93.33% compared to $0.21 per share a year ago [1][2] Financial Performance - The company posted revenues of $800.37 million for the quarter ended June 2025, which was 0.52% below the Zacks Consensus Estimate and a decrease from $805.97 million year-over-year [2] - Over the last four quarters, AdaptHealth has surpassed consensus EPS estimates two times and topped consensus revenue estimates two times [2] Stock Performance - Since the beginning of the year, AdaptHealth shares have declined by approximately 4.3%, contrasting with the S&P 500's gain of 7.6% [3] - The current status of estimate revisions has resulted in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market in the near future [6] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $0.33 on revenues of $801.8 million, and for the current fiscal year, it is $1.05 on revenues of $3.24 billion [7] - The outlook for the Medical - Products industry, to which AdaptHealth belongs, is currently in the bottom 38% of over 250 Zacks industries, suggesting potential challenges ahead [8]
AdaptHealth Corp. (AHCO) Lags Q2 Earnings and Revenue Estimates